The West of Ireland has one of the poorest ambulance response times in the country for life threatening cardiac emergencies.
According to the Irish Times, only a third of ambulances in the West arrived within the eight minute target of being called.
This is significantly short of the targets recommended by the Health Information and Quality Authority.
This compares with the East of the country where 60 per cent arrived within eight minutes, and the South where 40 per cent of ambulances arrived within target times.
All of these fall below the State’s 75 per cent response rate target.
Local TD says €2.5m funding “vital lifeline” to local radio
Galway Bay fm newsroom – A local TD says the announcement of 2.5 million euro in additional funding for the broadcasting sector is a “vital lifeline” for local radio.
The allocation has been made through the Sound and Vision Scheme, which provides grants for the creation of high-quality programmes.
Galway East Fine Gael TD Ciaran Cannon says local radio provides a very important public service and deserves greater support.
TFI Local Link to launch new service between Ballinasloe and Castlerea
Galway Bay fm newsroom – TFI Local Link Galway will launch a new service between Ballinasloe and Castlerea on Monday.
Route 546 will operate three times a day in each direction.
It’ll cover Castlerea, Williamstown, Glenamaddy, Kilkerrin, Moylough, Mountbellew, Caltra, Ahascragh and Ballinasloe.
The new service will also provide commuters with a new peak-time service that interchanges with direct services to Galway from Ballinasloe.
Galway company raises over €15m to develop revolutionary heart impant
Galway Bay fm newsroom – A Galway-based company has raised over 15 million euro in funding to develop a revolutionary heart impant.
AuriGen Medical has launched a crowdfunding campaign, with the funds going toward facilitating clinical trials.
The start-up company is based in ATU Galway and was founded by John Thomspson and Dr Tony O’Halloran.
Dr Thompson explains how funding and investment has progressed their development of the heart implant which aims to treat stroke and arrhythmia risk: